Reluctance to attend hospital tests and come forward about symptoms could be contributing to delays in lung cancer diagnosis, a Cancer Research UK survey of GPs across the UK shows.
The study of 1,000 GPs has helped to explain a decline in both diagnosis and treatment rates for the disease, with urgent referrals dropping by around a third (34%) since March last year.
Michelle Mitchell, Cancer Research UK’s chief executive, said: “We’re hugely concerned for people who have symptoms but haven’t come forward or are putting off further tests.”
Roughly 20,300 fewer people in England were urgently referred for suspected lung cancer between March 2020 and January 2021 compared to the same period the year before, while 9% fewer started treatment between April 2020 and January 2021.